Key operational steps include: (i) Multi-omic Profiling: Tumor samples undergo parallel assessment of genomic instability (HRD via scarHRD and TMB from WES) and immune fitness (STING pathway activity via scRNA-seq or phospho-flow) (68). The gene discussed is STING1; the disease is neoplasm.